1. Home
  2. ACCO vs ATYR Comparison

ACCO vs ATYR Comparison

Compare ACCO & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACCO
  • ATYR
  • Stock Information
  • Founded
  • ACCO 1893
  • ATYR 2005
  • Country
  • ACCO United States
  • ATYR United States
  • Employees
  • ACCO N/A
  • ATYR N/A
  • Industry
  • ACCO Publishing
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ACCO Consumer Discretionary
  • ATYR Health Care
  • Exchange
  • ACCO Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • ACCO 321.7M
  • ATYR 306.2M
  • IPO Year
  • ACCO N/A
  • ATYR 2015
  • Fundamental
  • Price
  • ACCO $3.36
  • ATYR $5.22
  • Analyst Decision
  • ACCO Buy
  • ATYR Strong Buy
  • Analyst Count
  • ACCO 1
  • ATYR 6
  • Target Price
  • ACCO $6.00
  • ATYR $20.20
  • AVG Volume (30 Days)
  • ACCO 887.3K
  • ATYR 2.5M
  • Earning Date
  • ACCO 07-31-2025
  • ATYR 08-12-2025
  • Dividend Yield
  • ACCO 8.90%
  • ATYR N/A
  • EPS Growth
  • ACCO N/A
  • ATYR N/A
  • EPS
  • ACCO N/A
  • ATYR N/A
  • Revenue
  • ACCO $1,624,700,000.00
  • ATYR N/A
  • Revenue This Year
  • ACCO N/A
  • ATYR $960.85
  • Revenue Next Year
  • ACCO $0.58
  • ATYR $1,283.47
  • P/E Ratio
  • ACCO N/A
  • ATYR N/A
  • Revenue Growth
  • ACCO N/A
  • ATYR N/A
  • 52 Week Low
  • ACCO $3.32
  • ATYR $1.42
  • 52 Week High
  • ACCO $6.44
  • ATYR $5.98
  • Technical
  • Relative Strength Index (RSI)
  • ACCO 34.11
  • ATYR 62.87
  • Support Level
  • ACCO $3.43
  • ATYR $5.02
  • Resistance Level
  • ACCO $3.88
  • ATYR $5.98
  • Average True Range (ATR)
  • ACCO 0.11
  • ATYR 0.45
  • MACD
  • ACCO -0.03
  • ATYR -0.04
  • Stochastic Oscillator
  • ACCO 7.14
  • ATYR 52.94

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: